BIOSENSING DIAGNOSTICS
Biosensing Diagnostics develops rapid, portable in vitro tests that detect viral infections and cancers at the point of care. The company combines a portable Surface Plasmon Resonance (SPR) platform with patented antibodies against native membrane biomarkers, magnetic particles for sample inactivation and concentration, and advanced surface chemistry to boost sensitivity and specificity. Results are assisted by a digital hub that uses artificial intelligence and machine learning for analysis and interpretation. The product is positioned as an SPR-based POCT diagnostic solution that meets regulatory standards for clinical use. Target customers include clinical laboratories, hospitals, and other healthcare providers seeking sensitive, fast diagnostic assays.
BIOSENSING DIAGNOSTICS
Biosensing Diagnostics develops rapid, portable in vitro tests that detect viral infections and cancers at the point of care. The company combines a portable Surface Plasmon Resonance (SPR) platform with patented antibodies against native membrane biomarkers, magnetic particles for sample inactivation and concentration, and advanced surface chemistry to boost sensitivity and specificity. Results are assisted by a digital hub that uses artificial intelligence and machine learning for analysis and interpretation. The product is positioned as an SPR-based POCT diagnostic solution that meets regulatory standards for clinical use. Target customers include clinical laboratories, hospitals, and other healthcare providers seeking sensitive, fast diagnostic assays.